Header cover image

Australian Pharmaceuticals & Biotech Profitable Climbers

Results

2

0 new

2 companies

Neuren Pharmaceuticals

Market Cap: AU$2.1b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

NEU

AU$16.46

7D

-3.0%

1Y

-0.1%

Aroa Biosurgery

Market Cap: AU$193.7m

Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.

ARX

AU$0.56

7D

-4.3%

1Y

-1.8%